Iridex Corp (IRIX)
NASDAQ:IRIX
US Market
Advertisement

Iridex (IRIX) Earnings Dates, Call Summary & Reports

Compare
133 Followers

Earnings Data

Report Date
Mar 05, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
Last Year’s EPS
-0.05
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 11, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth and successful cost-cutting measures leading to improved adjusted EBITDA and projections for positive cash flow. However, challenges such as a decrease in gross margin and market difficulties in Asia tempered the overall positive outlook.
Company Guidance
During the IRIDEX Third Quarter 2025 Earnings Conference Call, the company reported robust financial performance, achieving an 8% year-over-year revenue growth to $12.5 million, with notable strength in both glaucoma and retina product lines. Operating expenses were reduced by 12%, contributing to a significant improvement in adjusted EBITDA by $1.3 million compared to the previous year. Additionally, IRIDEX anticipates positive cash flows in the fourth quarter and aims for cash flow positive operations in 2026. The company also noted a 13% growth in the Cyclo G6 glaucoma product group, sales of 30 Cyclo G6 systems, and increased probe sales to 14,900 units, reflecting strong product utilization and demand. Despite facing challenges like the China tariff dispute and currency fluctuations in Japan, the overall international glaucoma and retina performance remained strong, driven by strategic initiatives and new distributor engagements. Furthermore, IRIDEX is working on enhancing gross margins through negotiations with contract manufacturers and relocating certain operations, expecting $165,000 in quarterly savings from 2026.
Year-Over-Year Revenue Growth
IRIDEX achieved a strong year-over-year revenue growth of 8% for the third quarter of 2025, reaching $12.5 million in revenue.
Reduction in Operating Expenses
Operating expenses were reduced by 12% in the third quarter of 2025 compared to the same period in 2024, and by 25% for the nine months ending September 27, 2025.
Improved Adjusted EBITDA
Adjusted EBITDA improved by $1.3 million compared to the prior year period, with a non-GAAP adjusted EBITDA loss of $131,000 for Q3 2025.
Growth in Glaucoma Product Group
The Cyclo G6 glaucoma product group revenue grew by 13% year-over-year, with system sales increasing to 30 units from 26 in the prior year period.
Positive Projections for Cash Flow
IRIDEX is on track to achieve positive cash flows in the fourth quarter of 2025 and sustained cash flow positivity in 2026.

Iridex (IRIX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

IRIX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 05, 2026
2025 (Q4)
- / -
-0.05
Nov 11, 2025
2025 (Q3)
- / -0.09
-0.1225.00% (+0.03)
Aug 12, 2025
2025 (Q2)
- / -0.06
-0.1662.50% (+0.10)
May 13, 2025
2025 (Q1)
- / -0.10
-0.2152.38% (+0.11)
Mar 27, 2025
2024 (Q4)
- / -0.05
-0.1872.22% (+0.13)
Nov 12, 2024
2024 (Q3)
-0.09 / -0.12
-0.11-9.09% (>-0.01)
Aug 08, 2024
2024 (Q2)
-0.12 / -0.16
-0.175.88% (+0.01)
May 14, 2024
2024 (Q1)
-0.12 / -0.21
-0.13-61.54% (-0.08)
Mar 26, 2024
2023 (Q4)
-0.05 / -0.18
-0.07-157.14% (-0.11)
Nov 14, 2023
2023 (Q3)
-0.13 / -0.11
-0.110.00% (0.00)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

IRIX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 11, 2025
$1.19$0.95-20.17%
Aug 12, 2025
$1.30$1.18-9.23%
May 13, 2025
$1.10$1.00-9.09%
Mar 27, 2025
$0.88$1.00+13.64%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Iridex Corp (IRIX) report earnings?
Iridex Corp (IRIX) is schdueled to report earning on Mar 05, 2026, After Close (Confirmed).
    What is Iridex Corp (IRIX) earnings time?
    Iridex Corp (IRIX) earnings time is at Mar 05, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is IRIX EPS forecast?
          Currently, no data Available
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis